Legal Representation
Attorney
Harold Milstein
USPTO Deadlines
Next Deadline
1336 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20230905)
Due Date
September 05, 2029
Grace Period Ends
March 05, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 5, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Sep 5, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jun 20, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 20, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 31, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 11, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 10, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 9, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 9, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 10, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 10, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 10, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 10, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 15, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Apr 15, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Apr 15, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Feb 8, 2022 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Feb 7, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 3, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Diagnostic kits comprised of reagents and assays for use in disease detection; medical diagnostic preparations for RNA-based sequencing or DNA-based sequencing
First Use Anywhere:
20200400
First Use in Commerce:
20200400
Class 044
Medical testing for diagnostic or treatment purposes; medical diagnostic testing, monitoring, and reporting services; medical testing for diagnostic or treatment purposes featuring DNA sequencing or RNA sequencing
First Use Anywhere:
20200400
First Use in Commerce:
20200400
Additional Information
Design Mark
The mark consists of stylized "KARIUS" and "TEST" words with a vertical line between them.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"TEST"